{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["128(2)"],"submitter":["de Ruigh AA"],"pubmed_abstract":["<h4>Objective</h4>To assess the effect of transabdominal amnioinfusion or no intervention on long-term outcomes in children born after second-trimester prelabour rupture of the membranes (PROM between 16<sup>+0/7</sup> -24<sup>+0/7</sup>  weeks) and oligohydramnios.<h4>Population</h4>Follow up of infants of women who participated in the randomised controlled trial: PPROMEXIL-III (NTR3492).<h4>Methods</h4>Surviving infants were invited for neurodevelopmental assessment up to 5 years of corrected age using a Bayley Scales of Infant and Toddler Development or a Wechsler Preschool and Primary Scale of Intelligence. Parents were asked to complete several questionnaires.<h4>Main outcome measures</h4>Neurodevelopmental outcomes were measured. Mild delay was defined as -1 standard deviation (SD), "],"journal":["BJOG : an international journal of obstetrics and gynaecology"],"pagination":["292-301"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7818451"],"repository":["biostudies-literature"],"pubmed_title":["Child outcomes after amnioinfusion compared with no intervention in women with second-trimester rupture of membranes: a long-term follow-up study of the PROMEXIL-III trial."],"pmcid":["PMC7818451"],"pubmed_authors":["Woiski M","van Teeffelen AS","van Kempen L","Simons NE","de Ruigh AA","Oepkes D","van Wassenaer-Leemhuis AG","Pajkrt E","Aarnoudse-Moens C","van 't Hooft J","van de Beek C","Roseboom TJ","Derks JB","Mol BW","Porath MM","Haak MC","Duijnhoven RG"],"additional_accession":[]},"is_claimable":false,"name":"Child outcomes after amnioinfusion compared with no intervention in women with second-trimester rupture of membranes: a long-term follow-up study of the PROMEXIL-III trial.","description":"<h4>Objective</h4>To assess the effect of transabdominal amnioinfusion or no intervention on long-term outcomes in children born after second-trimester prelabour rupture of the membranes (PROM between 16<sup>+0/7</sup> -24<sup>+0/7</sup>  weeks) and oligohydramnios.<h4>Population</h4>Follow up of infants of women who participated in the randomised controlled trial: PPROMEXIL-III (NTR3492).<h4>Methods</h4>Surviving infants were invited for neurodevelopmental assessment up to 5 years of corrected age using a Bayley Scales of Infant and Toddler Development or a Wechsler Preschool and Primary Scale of Intelligence. Parents were asked to complete several questionnaires.<h4>Main outcome measures</h4>Neurodevelopmental outcomes were measured. Mild delay was defined as -1 standard deviation (SD), ","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Jan","modification":"2025-05-31T23:03:08.876Z","creation":"2025-05-31T23:03:08.876Z"},"accession":"S-EPMC7818451","cross_references":{"pubmed":["31984652"],"doi":["10.1111/1471-0528.16115"]}}